Fisher Asset Management
CPRX

Fisher Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Fisher Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
82,169
-663
-0.8% -$15.8K ﹤0.01% 572
2025
Q4 		$1.93M Sell
82,832
-305
-0.4% -$6.79K ﹤0.01% 562
2025
Q3 		$1.64M Hold
83,137
– – ﹤0.01% 610
2025
Q2 		$1.8M Buy
83,137
+969
+1% +$22.9K ﹤0.01% 590
2025
Q1 		$1.99M Sell
82,168
-4,679
-5% -$105K ﹤0.01% 581
2024
Q4 		$1.81M Buy
86,847
+50
+0.1% +$1.07K ﹤0.01% 593
2024
Q3 		$1.73M Sell
86,797
-18,738
-18% -$347K ﹤0.01% 604
2024
Q2 		$1.63M Sell
105,535
-7,084
-6% -$110K ﹤0.01% 617
2024
Q1 		$1.8M Buy
112,619
+955
+0.9% +$14.4K ﹤0.01% 609
2023
Q4 		$1.88M Hold
111,664
– – ﹤0.01% 599
2023
Q3 		$1.31M Hold
111,664
– – ﹤0.01% 694
2023
Q2 		$1.5M Hold
111,664
– – ﹤0.01% 700
2023
Q1 		$1.85M Sell
111,664
-21,904
-16% -$361K ﹤0.01% 668
2022
Q4 		$2.48M Sell
133,568
-157,329
-54% -$2.42M ﹤0.01% 613
2022
Q3 		$3.73M Hold
290,897
– – ﹤0.01% 491
2022
Q2 		$2.04M Buy
290,897
+30,429
+12% +$223K ﹤0.01% 533
2022
Q1 		$2.16M Sell
260,468
-5,084
-2% -$35.9K ﹤0.01% 541
2021
Q4 		$1.8M Buy
265,552
+63,751
+32% +$419K ﹤0.01% 575
2021
Q3 		$1.07M Buy
+201,801
New +$1.1M ﹤0.01% 607

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management's CPRX Position: Q1 2026 in Review

Fisher Asset Management reduced its Catalyst Pharmaceutical (CPRX) stake by 0.8% in Q1 2026, selling an estimated $15.8K and leaving 82,169 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Fisher Asset Management first reported a position in CPRX in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.73M in Q3 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Fisher Asset Management held 82,169 shares of Catalyst Pharmaceutical worth $2.03M as of Q1 2026.
  • Fisher Asset Management sold 663 Catalyst Pharmaceutical shares in Q1 2026, an estimated $15.8K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Fisher Asset Management's portfolio in Q1 2026, its #572 holding.
  • Fisher Asset Management first reported a position in Catalyst Pharmaceutical in Q3 2021 and has held it in 19 quarters since.
  • Fisher Asset Management's Catalyst Pharmaceutical position peaked at $3.73M in Q3 2022.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.